Folyóiratcikkek tallózása szerző szerint "Kéri György"

1-7 / 7

Decreased functional activity of multidrug resistance protein in primary colorectal cancer

Micsik Tamás; Lőrincz András; Mersich Tamás; Baranyai Zsolt; Besznyák István Endre; Dede Kristóf; Zaránd Attila; Jakab Ferenc; Szöllösi Krecsák László; Kéri György; Schwab Richard; Peták István (2015)
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.

Garamvölgyi Rita; Dobos J; Sipos A; Boros S; Illyes E; Kéri György; Őrfi László (2016)

Melanoma is an aggressive form of skin cancer and it is generally associated with poor prognosis in patients with late-stage disease. Due to the increasing occurrence of melanoma, there is a need for the development of ...
Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases.

Booij TH; Klop MJ; Yan K; Szantai-Kis C; Szokol Bálint; Őrfi László; Kéri György; van de Water B; Price LS (2016)

3D tissue cultures provide a more physiologically relevant context for the screening of compounds, compared with 2D cell cultures. Cells cultured in 3D hydrogels also show complex phenotypes, increasing the scope for ...
Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell lines

Mavromatidis V; Varga Z; Wáczek Frigyes; Orfi Z; Őrfi László; Kéri György; Mosialos G (2014)

Epstein-Barr virus (EBV) is a human herpesvirus, which is causally associated with the development of several B lymphocytic malignancies that include Burkitt's lymphomas, Hodgkin's disease, AIDS and posttransplant associated ...
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes

Simon-Szabó Laura; Kokas Márton; Greff Zolzán; Boros Sándor; Bánhegyi Péter; Zsákai Lilián; Szántai-Kis Csaba; Vántus Tibor; Mandl József; Bánhegyi Gábor; Vályi-Nagy István; Őrfi László; Axel Ullrich; Csala Miklós; Kéri György (2016)
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

Herrero Ana; Pinto Adan; Colon-Bolea Paula; Casar Berta; Jones Mary; Agudo-Ibanez Lorena; Vidal Rebeca; Tenbaum Stephan P; Nuciforo Paolo; Valdizan Elsa M; Horvath Zoltan; Őrfi László; Pineda-Lucena Antonio; Bony Emilie; Kéri György; Rivas German; Pazos Angel; Gozalbes Rafael; Palmer Hector G; Hurlstone Adam; Crespo Piero (2015)

Nearly 50% of human malignancies exhibit unregulated RAS-ERK signaling; inhibiting it is a valid strategy for antineoplastic intervention. Upon activation, ERK dimerize, which is essential for ERK extranuclear, but not for ...
Targeting vascular endothelial growth factor receptor 2 and protein kinase d1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Varga Attila; Gyulavari Pál; Greff Zoltán; Futosi Krisztina; Németh Tamás; Simon-Szabó Laura; Kerekes Krisztina; Szántai-Kis Csaba; Brauswetter Diána; Kokas Márton; Borbély Gábor; Erdei Anna; Mócsai Attila; Kéri György; Vántus Tibor (2015)

Emerging evidence suggests that the vascular endothelial growth factor receptor 2 (VEGFR2) and protein kinase D1 (PKD1) signaling axis plays a critical role in normal and pathological angiogenesis and inflammation related ...

1-7 / 7

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban
Ebben a gyűjteményben

Hozzáférésem

Bejelentkezés

Folyóiratcikkek tallózása szerző szerint "Kéri György"

DSpace/Manakin Repository

Folyóiratcikkek tallózása szerző szerint "Kéri György"

Keresés

Tallózás

Teljes repozitórumban

Ebben a gyűjteményben

Hozzáférésem